Search

everythinglearnresearchcommunity

for

Search:↓

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Targeted immunotherapies may offer better treatment for alopecia areata by controlling inflammation and immune responses.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Immune therapy for cancer can cause hair loss scars in some patients.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

A new one-step test can quickly identify skin cancer during surgery.

The 3D skin model mimics pemphigus vulgaris and helps test treatments.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

CS12192 effectively treats alopecia areata with better safety than current options.

TLR7-based compounds may help manage chemotherapy-induced hair loss.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Allergic reactions to blood thinners are rare but can be serious, requiring careful testing and alternative treatments.

Plasmatherapy improves immune status in vitiligo patients, especially those with segmental vitiligo.

Androgens reduce macrophage receptor expression, affecting immune response, while antiandrogens counteract this effect.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.

New mouse models of Pemphigus show severe symptoms and need better treatments.

Langerhans cells are crucial for skin immunity and allergic reactions.

Protein microarrays are highly sensitive tools useful for disease diagnosis and studying proteins.